非结核分枝杆菌病治疗药品超说明书用法专家共识

Expert consensus on off-label use of drugs for non-tuberculous mycobacteria

针对非结核分枝杆菌病的治疗药品存在或者没有适应证,或者超疗程、超剂量等情况,中国防痨协会非结核分枝杆菌专业分会组织相关专家对大环内酯类、利福霉素类、氨基糖苷类、氟喹诺酮类、β-内酰胺类、四环素类药品,以及利奈唑胺、氯法齐明、贝达喹啉、复方磺胺甲噁唑等治疗非结核分枝杆菌病药品的超说明书用法达成共识并形成此文件,期望对临床医生提供指导。

For the treatment of non-tuberculous mycobacterial disease drugs or no indication,or overtreatment,over-dose,etc.The Non-tuberculous Mycobacterial Branch of the Chinese Antituberculosis Association organized relevant experts on treatment drugs such as macrolides,rifamycin,aminoglycosides,fluoroquinolones,β-lactams,tetracyclines,linezolid,clofazimine,bedaquiline,trimethoprim-sulfamethoxazole and other drugs for non-tuberculous mycobacterial disease to reach a consensus,looking forward to providing guidance to clinicians.